Logo image of CPRI

CAPRI HOLDINGS LTD (CPRI) Stock Fundamental Analysis

NYSE:CPRI - New York Stock Exchange, Inc. - VGG1890L1076 - Common Stock - Currency: USD

21.3  -0.55 (-2.52%)

After market: 21.35 +0.05 (+0.23%)

Fundamental Rating

3

Overall CPRI gets a fundamental rating of 3 out of 10. We evaluated CPRI against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CPRI has a bad profitability rating. Also its financial health evaluation is rather negative. CPRI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CPRI had positive earnings in the past year.
CPRI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CPRI reported negative net income in multiple years.
In the past 5 years CPRI always reported a positive cash flow from operatings.
CPRI Yearly Net Income VS EBIT VS OCF VS FCFCPRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of CPRI (-17.09%) is worse than 87.76% of its industry peers.
The Return On Equity of CPRI (-94.48%) is worse than 85.71% of its industry peers.
CPRI has a worse Return On Invested Capital (2.08%) than 63.27% of its industry peers.
CPRI had an Average Return On Invested Capital over the past 3 years of 10.00%. This is in line with the industry average of 11.76%.
The last Return On Invested Capital (2.08%) for CPRI is well below the 3 year average (10.00%), which needs to be investigated, but indicates that CPRI had better years and this may not be a problem.
Industry RankSector Rank
ROA -17.09%
ROE -94.48%
ROIC 2.08%
ROA(3y)5.34%
ROA(5y)2.47%
ROE(3y)17.04%
ROE(5y)7.59%
ROIC(3y)10%
ROIC(5y)8.43%
CPRI Yearly ROA, ROE, ROICCPRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

Looking at the Operating Margin, with a value of 2.55%, CPRI is doing worse than 65.31% of the companies in the same industry.
In the last couple of years the Operating Margin of CPRI has declined.
The Gross Margin of CPRI (63.97%) is better than 85.71% of its industry peers.
CPRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.55%
PM (TTM) N/A
GM 63.97%
OM growth 3Y-10.43%
OM growth 5Y-15.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y1.24%
CPRI Yearly Profit, Operating, Gross MarginsCPRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

CPRI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CPRI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CPRI has less shares outstanding
Compared to 1 year ago, CPRI has a worse debt to assets ratio.
CPRI Yearly Shares OutstandingCPRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CPRI Yearly Total Debt VS Total AssetsCPRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CPRI has an Altman-Z score of 2.40. This is not the best score and indicates that CPRI is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CPRI (2.40) is worse than 61.22% of its industry peers.
CPRI has a debt to FCF ratio of 4.41. This is a neutral value as CPRI would need 4.41 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.41, CPRI is in line with its industry, outperforming 44.90% of the companies in the same industry.
CPRI has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
CPRI's Debt to Equity ratio of 1.36 is on the low side compared to the rest of the industry. CPRI is outperformed by 81.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 4.41
Altman-Z 2.4
ROIC/WACC0.26
WACC8.05%
CPRI Yearly LT Debt VS Equity VS FCFCPRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CPRI has a Current Ratio of 1.21. This is a normal value and indicates that CPRI is financially healthy and should not expect problems in meeting its short term obligations.
CPRI's Current ratio of 1.21 is on the low side compared to the rest of the industry. CPRI is outperformed by 89.80% of its industry peers.
A Quick Ratio of 0.59 indicates that CPRI may have some problems paying its short term obligations.
CPRI has a worse Quick ratio (0.59) than 97.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.59
CPRI Yearly Current Assets VS Current LiabilitesCPRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1

3. Growth

3.1 Past

CPRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.39%.
Measured over the past years, CPRI shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.86% on average per year.
CPRI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.34%.
Measured over the past years, CPRI shows a decrease in Revenue. The Revenue has been decreasing by -0.26% on average per year.
EPS 1Y (TTM)-61.39%
EPS 3Y22.68%
EPS 5Y-6.86%
EPS Q2Q%-62.5%
Revenue 1Y (TTM)-12.34%
Revenue growth 3Y8.39%
Revenue growth 5Y-0.26%
Sales Q2Q%-11.63%

3.2 Future

Based on estimates for the next years, CPRI will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.08% on average per year.
The Revenue is expected to decrease by -0.67% on average over the next years.
EPS Next Y-70.22%
EPS Next 2Y-40.67%
EPS Next 3Y-18.88%
EPS Next 5Y10.08%
Revenue Next Year-13.9%
Revenue Next 2Y-7.14%
Revenue Next 3Y-4.11%
Revenue Next 5Y-0.67%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPRI Yearly Revenue VS EstimatesCPRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
CPRI Yearly EPS VS EstimatesCPRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.65 indicates a correct valuation of CPRI.
CPRI's Price/Earnings ratio is a bit cheaper when compared to the industry. CPRI is cheaper than 75.51% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CPRI is valued rather cheaply.
CPRI is valuated rather expensively with a Price/Forward Earnings ratio of 17.34.
CPRI's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, CPRI is valued a bit cheaper.
Industry RankSector Rank
PE 13.65
Fwd PE 17.34
CPRI Price Earnings VS Forward Price EarningsCPRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CPRI's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CPRI indicates a somewhat cheap valuation: CPRI is cheaper than 77.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.5
EV/EBITDA 11.86
CPRI Per share dataCPRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

CPRI's earnings are expected to decrease with -18.88% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-40.67%
EPS Next 3Y-18.88%

0

5. Dividend

5.1 Amount

No dividends for CPRI!.
Industry RankSector Rank
Dividend Yield N/A

CAPRI HOLDINGS LTD

NYSE:CPRI (2/21/2025, 8:10:44 PM)

After market: 21.35 +0.05 (+0.23%)

21.3

-0.55 (-2.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)05-27 2025-05-27/amc
Inst Owners85.46%
Inst Owner Change5.92%
Ins Owners2.31%
Ins Owner Change0%
Market Cap2.51B
Analysts73.04
Price Target27.04 (26.95%)
Short Float %5.47%
Short Ratio1.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.43%
Min EPS beat(2)-33.59%
Max EPS beat(2)-15.28%
EPS beat(4)0
Avg EPS beat(4)-44.7%
Min EPS beat(4)-93.35%
Max EPS beat(4)-15.28%
EPS beat(8)2
Avg EPS beat(8)-29.17%
EPS beat(12)5
Avg EPS beat(12)-17.39%
EPS beat(16)9
Avg EPS beat(16)120.11%
Revenue beat(2)0
Avg Revenue beat(2)-5.94%
Min Revenue beat(2)-10.23%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-7.22%
Min Revenue beat(4)-10.23%
Max Revenue beat(4)-1.64%
Revenue beat(8)2
Avg Revenue beat(8)-4.64%
Revenue beat(12)4
Avg Revenue beat(12)-2.88%
Revenue beat(16)8
Avg Revenue beat(16)-0.14%
PT rev (1m)8.16%
PT rev (3m)-40.3%
EPS NQ rev (1m)-157.56%
EPS NQ rev (3m)-127.85%
EPS NY rev (1m)-36.26%
EPS NY rev (3m)-52.69%
Revenue NQ rev (1m)-11.36%
Revenue NQ rev (3m)-18.99%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-4.3%
Valuation
Industry RankSector Rank
PE 13.65
Fwd PE 17.34
P/S 0.54
P/FCF 7.5
P/OCF 5.17
P/B 2.35
P/tB N/A
EV/EBITDA 11.86
EPS(TTM)1.56
EY7.32%
EPS(NY)1.23
Fwd EY5.77%
FCF(TTM)2.84
FCFY13.34%
OCF(TTM)4.12
OCFY19.35%
SpS39.27
BVpS9.06
TBVpS-5.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.09%
ROE -94.48%
ROCE 2.64%
ROIC 2.08%
ROICexc 2.26%
ROICexgc 3.96%
OM 2.55%
PM (TTM) N/A
GM 63.97%
FCFM 7.24%
ROA(3y)5.34%
ROA(5y)2.47%
ROE(3y)17.04%
ROE(5y)7.59%
ROIC(3y)10%
ROIC(5y)8.43%
ROICexc(3y)10.37%
ROICexc(5y)8.83%
ROICexgc(3y)23.03%
ROICexgc(5y)20.34%
ROCE(3y)12.66%
ROCE(5y)10.67%
ROICexcg growth 3Y-5.18%
ROICexcg growth 5Y-29.13%
ROICexc growth 3Y2.41%
ROICexc growth 5Y-15.56%
OM growth 3Y-10.43%
OM growth 5Y-15.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y1.24%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 4.41
Debt/EBITDA 4.66
Cap/Depr 77.84%
Cap/Sales 3.26%
Interest Coverage 1.37
Cash Conversion 155.77%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.59
Altman-Z 2.4
F-Score5
WACC8.05%
ROIC/WACC0.26
Cap/Depr(3y)98.22%
Cap/Depr(5y)87.32%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.39%
EPS 3Y22.68%
EPS 5Y-6.86%
EPS Q2Q%-62.5%
EPS Next Y-70.22%
EPS Next 2Y-40.67%
EPS Next 3Y-18.88%
EPS Next 5Y10.08%
Revenue 1Y (TTM)-12.34%
Revenue growth 3Y8.39%
Revenue growth 5Y-0.26%
Sales Q2Q%-11.63%
Revenue Next Year-13.9%
Revenue Next 2Y-7.14%
Revenue Next 3Y-4.11%
Revenue Next 5Y-0.67%
EBIT growth 1Y-71.5%
EBIT growth 3Y-2.91%
EBIT growth 5Y-16.05%
EBIT Next Year-32.95%
EBIT Next 3Y0.37%
EBIT Next 5Y10.83%
FCF growth 1Y-14.76%
FCF growth 3Y-38.38%
FCF growth 5Y-25.13%
OCF growth 1Y-19.93%
OCF growth 3Y-20.89%
OCF growth 5Y-14.94%